Skip to main content
. 2018 Oct 5;14(3):313–320. doi: 10.1016/j.ajps.2018.08.007

Table 6.

Pharmacokinetic parameters of the reference or F5 tablet after oral administration in beagle dogs (n = 6, crossover study).

Composition Tmax (h) Cmax (ng/ml) AUC0–24h (ng·h/ml) Relative BA% (to the reference)
Reference 1.7 ± 0.5 67.3 ± 17.9 1964.7 ± 546.1
F5 1.2 ± 0.7 61.2 ± 16.9 1815.6 ± 532.4 92.4
P-value N/A 0.5990 0.5593

N/A: Not assessed